Clarify

250mg
  • Mode of action

    Clarify inhibits protein synthesis by binding to 50s ribosomal subunits of susceptible organisms. It has activity against susceptible streptococci and staphylococci as well as other species including B catarrhalis, L spp, C. Travhomans and U urealyticum,

  • Indication

    • Respiratory tract infection
    • Skin and soft tissue infection
    • Leprosy
    • Peptic ulcer diseases
    • Pharyngitis
    • Tonsillitis
    • Acute maxillary sinusitis
    • Acute bacterial exacerbation of chronic bronchitis
    • Pneumonia
    • Legionellosis
    • Helicobacter pylori
    • Lyme disease
    • Community acquired pneumonia